Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Clinical trial NCT02392780 · UNKNOWN
Trial details
- NCT number
- NCT02392780
- Sponsor
- moshe yeshurun
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.